Frequently bought together

Brand : RHINATHIOL

RHINATHIOL 2% CHILDREN SYRUP 125ML

9.3

Sku : I-005536
Key features
RHINATHIOL 2% Children's Syrup 125 ml is a mucolytic syrup containing carbocysteine 20 mg/ml. It acts as a mucoregulator/mucolytic by reducing sputum viscosity and improving mucociliary clearance through modulation of mucus glycoprotein composition, restoring the sialomucin/fucoprotein balance rather than directly cleaving disulfide bonds. Indicated as adjunctive treatment for respiratory tract disorders associated with excessive or viscous mucus, including acute or chronic bronchitis and COPD with mucus hypersecretion. Available by prescription as a 125 ml syrup.
- Brand: RHINATHIOL
- Active Ingredient: CARBOCYSTEINE 20mg/ml
- Strength: 20mg/ml
- Dosage Form: Syrup
- Pack Size: 125 ml
- Route: Oral use
- Prescription Status: Prescription
- Therapeutic Class: Respiratory
- Pharmacological Group: Cough & Cold Preparations
- Drug Class: Mucolytic Agent (Thiol-derivative)
- Manufacturer: sanofi-aventis
- Country of Origin: France
- SFDA Registration No.: 3-5827-25
- Shelf Life: 36 months
- Storage: store below 25°c
- Symptom Target: Cough
- Sedating: No

Frequently bought together

Description

Specification

Indications

Approved Uses

Adjunctive treatment of respiratory tract disorders associated with excessive/viscous mucus (productive cough), such as acute or chronic bronchitis and COPD with mucus hypersecretion.

Dosage & Administration

Maximum Dose

Not reliably determinable from the provided verified API data; follow the product’s local SmPC/label for age-based maximum daily dose

Side Effects

Common Side Effects

Gastrointestinal upset (nausea, vomiting, diarrhea, epigastric/abdominal pain) and skin rash/urticaria; headache can occur but is less common.

Safety & Warnings

Age Restriction

Contraindicated in children under 2 years

Drug Interactions

Food Interaction

No restriction.

Storage & Patient Advice

Stopping the Medicine

Safe to stop anytime once symptoms resolve; no tapering required

Monitoring Requirements

No routine laboratory monitoring is required; clinically monitor symptom response and adverse effects, especially gastrointestinal intolerance or signs of GI bleeding in at-risk patients.

Pharmacology

Mechanism of Action

Mucoregulator/mucolytic: reduces sputum viscosity and improves mucociliary clearance primarily by modulating mucus glycoprotein composition (restoring sialomucin/fucoprotein balance) rather than directly cleaving disulfide bonds (that mechanism is more typical of acetylcysteine).

Excretion

Primarily renal excretion in urine as a mixture of unchanged drug and metabolites

Protein Binding

Protein binding: not well established/variable in references (often reported as moderate, but not reliably quantified)

Product Information

Composition per Dose

Each 5 ml: 100 mg carbocysteine

Generic Availability

Yes

OTC Alternatives

This product is prescription-only per SFDA; OTC availability of alternative mucolytics (e.g., ambroxol, bromhexine) depends on local regulations and cannot be assumed.